N patients (%) | |
---|---|
P65 expression | |
Negative | 144 (95) |
Positive | 7 (5) |
Age | |
≤ 60 years | 94 (62) |
≥ 61 years | 57 (38) |
Gender | |
Female | 36 (24) |
Male | 115 (76) |
Karnofsky performance score | |
≤ 70 | 77 (51) |
≥ 80 | 74 (49) |
Hemoglobin level pre-RT | |
< 12 g/dl | 49 (32) |
≥ 12 g/dl | 102 (68) |
Tumor Site | |
Oropharynx | 62 (41) |
Oral Cavity/Floor of mouth | 31 (21) |
Hypopharynx | 22 (15) |
Larynx | 36 (24) |
Histologic grade | |
G1-2 | 61 (40) |
G3 | 90 (60) |
HPV status | |
Negative | 129 (85) |
Positive | 19 (13) |
Not available | 3 (2) |
T-classification | |
T1-T2 | 71 (47) |
T3-T4 | 80 (53) |
N-classification | |
N0-N2a | 55 (36) |
N2b-N3 | 96 (64) |
AJCC stage | |
Stage III | 48 (32) |
Stage IV | 103 (68) |
Extent of resection | |
Complete | 123 (81) |
Incomplete | 28 (19) |
Chemotherapy | |
No | 82 (54) |
Yes | 69 (46) |